Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
38
Frequently Asked Questions
What is Market Cap of Nemaura Medical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nemaura Medical Inc market cap is $1.57M.
What is the 52-week high for Nemaura Medical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nemaura Medical Inc 52 week high is $1.25 as of September 18, 2025.
What is the 52-week low for Nemaura Medical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nemaura Medical Inc 52 week low is $0.0525 as of September 18, 2025.
What is Nemaura Medical Inc stock price today?
Nemaura Medical Inc stock price today is $0.0549.
What was Nemaura Medical Inc stock price yesterday?
Nemaura Medical Inc stock price yesterday was $0.0542.
What is the PE ratio of Nemaura Medical Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nemaura Medical Inc’s P/E ratio is -0.14.
What is the Price-to-Book ratio of Nemaura Medical Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nemaura Medical Inc P/B ratio is -0.0879.
What is Nemaura Medical Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Nemaura Medical Inc's EBITDA is -2.93.
What is the 50-day moving average of Nemaura Medical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nemaura Medical Inc 50-day moving average is $0.08.
